Literature DB >> 11802745

Reflections on hypertension control rates: a message from the director of the National Heart, Lung, and Blood Institute.

Claude Lenfant.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11802745     DOI： 10.1001/archinte.162.2.131

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  9 in total

Review 1.  Prevention of heart failure in the elderly: when, where and how to begin?

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Public education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in Canada.

Authors:  N R Campbell; Robert Petrella; Janusz Kaczorowski
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 3.  Can we justify goal blood pressure of <140/90 mm Hg in most hypertensives?

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

4.  Canada Chair in hypertension prevention and control: a pilot project.

Authors:  Norm R C Campbell
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

5.  Efficacy of a family practice-based lifestyle intervention program to increase physical activity and reduce clinical and physiological markers of vascular health in patients with high normal blood pressure and/or high normal blood glucose (SNAC): study protocol for a randomized controlled trial.

Authors:  Robert J Petrella; Kuni Aizawa; Kevin Shoemaker; Tom Overend; Len Piche; Mauricio Marin; Sheree Shapiro; Sophie Atkin
Journal:  Trials       Date:  2011-02-16       Impact factor: 2.279

6.  Continued improvement of cardiovascular mortality in Hungary--impact of increased cardio-metabolic prescriptions.

Authors:  Sandor Balogh; Renata Papp; Peter Jozan; Albert Csaszar
Journal:  BMC Public Health       Date:  2010-07-15       Impact factor: 3.295

7.  Proactive multifactorial intervention strategy reduces the risk of cardiovascular disease estimated with region-specific risk assessment models in Pacific Asian patients participating in the CRUCIAL trial.

Authors:  Eun Joo Cho; Jae Hyung Kim; Santosh Sutradhar; Carla Yunis; Mogens Westergaard
Journal:  J Korean Med Sci       Date:  2013-11-26       Impact factor: 2.153

8.  Genome-wide study of resistant hypertension identified from electronic health records.

Authors:  Logan Dumitrescu; Marylyn D Ritchie; Joshua C Denny; Nihal M El Rouby; Caitrin W McDonough; Yuki Bradford; Andrea H Ramirez; Suzette J Bielinski; Melissa A Basford; High Seng Chai; Peggy Peissig; David Carrell; Jyotishman Pathak; Luke V Rasmussen; Xiaoming Wang; Jennifer A Pacheco; Abel N Kho; M Geoffrey Hayes; Martha Matsumoto; Maureen E Smith; Rongling Li; Rhonda M Cooper-DeHoff; Iftikhar J Kullo; Christopher G Chute; Rex L Chisholm; Gail P Jarvik; Eric B Larson; David Carey; Catherine A McCarty; Marc S Williams; Dan M Roden; Erwin Bottinger; Julie A Johnson; Mariza de Andrade; Dana C Crawford
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

Review 9.  The hypertension management program: identifying opportunities for improvement.

Authors:  Susan K Maue; James H Jackson; Bruce A Weiss; Marc L Rivo; Vishu Jhaveri; Barbara Lennert
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.